Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_assertion type Assertion NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_head.
- NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_assertion description "[Nine proteins involved in glycolysis (triose-phosphate isomerase (TPI), phosphoglycerate kinase 1 (PGK1), and enolase 1 (ENO1)), lipid synthesis (fatty acid synthase (FASN)), stress-mediated chaperonage (heat shock protein 27 (Hsp27)), and antioxidant and detoxification pathways (haptoglobin, aldo-keto reductase (AKR), glyoxalase I (GLO), and prolyl-4-hydrolase beta-isoform (P4HB)) were found to be up-regulated in HER-2/neu-positive breast tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_provenance.
- NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_assertion evidence source_evidence_literature NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_provenance.
- NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_assertion SIO_000772 16048908 NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_provenance.
- NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_assertion wasDerivedFrom befree-2016 NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_provenance.
- NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_assertion wasGeneratedBy ECO_0000203 NP505988.RA_eGXodDByU9JVc871kOxOv-GjVQ2OJK1u9eOIVVDzJk130_provenance.